Cargando…
P775: LONG-TERM EFFICACY AND SAFETY OF POZELIMAB MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Autores principales: | Jang, Jun-Ho, Wong, Raymond, Weyne, Jonathan, Chaudhari, Umesh, Miller, Jutta, Nguyen, Quang P., Griffin, Morag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430539/ http://dx.doi.org/10.1097/01.HS9.0000970004.43570.16 |
Ejemplares similares
-
P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
por: Jang, Jun-Ho, et al.
Publicado: (2023) -
P797: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF COMBINATION POZELIMAB AND CEMDISIRAN THERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO SWITCH FROM ECULIZUMAB
por: Kelly, Richard, et al.
Publicado: (2023) -
Safety and efficacy of pegcetacoplan in paroxysmal nocturnal
hemoglobinuria
por: Wong, Raymond S.M.
Publicado: (2022) -
Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria
por: Patir, Pusem, et al.
Publicado: (2015) -
Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria
por: Mon Père, Nathaniel, et al.
Publicado: (2018)